29
Dec
New Delhi [India], December 29: AYUSH medicines don’t float in regulatory limbo. They operate under a dense, rule-heavy system that most critics never bother to read. Here’s what actually keeps Ayurveda, Siddha, Unani and Homoeopathy drugs in check. India’s AYUSH sector sits at an awkward crossroads. Hugely popular. Deeply traditional. Constantly questioned. What rarely gets attention is the regulatory scaffolding holding it together. It exists. It’s detailed. And it’s far from symbolic. At the centre of this system is AYUSH drug quality regulation, a framework built on testing, surveillance, certification and enforcement. Let’s break it down without the fog. PCIM&H…
